Unknown

Dataset Information

0

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).


ABSTRACT: The lungs are the second most common site of metastasis for colorectal cancer (CRC) after the liver. Rectal cancer is associated with a higher incidence of lung metastases compared to colon cancer. In China, the proportion of rectal cancer cases is around 50%, much higher than that in Western countries (nearly 30%). However, there is no available consensus or guideline focusing on CRC with lung metastases. We conducted an extensive discussion and reached a consensus of management for lung metastases in CRC based on current research reports and the experts' clinical experiences and knowledge. This consensus provided detailed approaches of diagnosis and differential diagnosis and provided general guidelines for multidisciplinary therapy (MDT) of lung metastases. We also focused on recommendations of MDT management of synchronous lung metastases and initial metachronous lung metastases. This consensus might improve clinical practice of CRC with lung metastases in China and will encourage oncologists to conduct more clinical trials to obtain high-level evidences about managing lung metastases.

SUBMITTER: Li J 

PROVIDER: S-EPMC6376656 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).

Li Jian J   Yuan Ying Y   Yang Fan F   Wang Yi Y   Zhu Xu X   Wang Zhenghang Z   Zheng Shu S   Wan Desen D   He Jie J   Wang Jianping J   Ba Yi Y   Bai Chunmei C   Bai Li L   Bai Wei W   Bi Feng F   Cai Kaican K   Cai Muyan M   Cai Sanjun S   Chen Gong G   Chen Keneng K   Chen Lin L   Chen Pengju P   Chi Pan P   Dai Guanghai G   Deng Yanhong Y   Ding Kefeng K   Fan Qingxia Q   Fang Weijia W   Fang Xuedong X   Feng Fengyi F   Fu Chuangang C   Fu Qihan Q   Gu Yanhong Y   He Yulong Y   Jia Baoqing B   Jiang Kewei K   Lai Maode M   Lan Ping P   Li Enxiao E   Li Dechuan D   Li Jin J   Li Leping L   Li Ming M   Li Shaolei S   Li Yexiong Y   Li Yongheng Y   Li Zhongwu Z   Liang Xiaobo X   Liang Zhiyong Z   Lin Feng F   Lin Guole G   Liu Hongjun H   Liu Jianzhong J   Liu Tianshu T   Liu Yunpeng Y   Pan Hongming H   Pan Zhizhong Z   Pei Haiping H   Qiu Meng M   Qu Xiujuan X   Ren Li L   Shen Zhanlong Z   Sheng Weiqi W   Song Chun C   Song Lijie L   Sun Jianguo J   Sun Lingyu L   Sun Yingshi Y   Tang Yuan Y   Tao Min M   Wang Chang C   Wang Haijiang H   Wang Jun J   Wang Shubin S   Wang Xicheng X   Wang Xishan X   Wang Ziqiang Z   Wu Aiwen A   Wu Nan N   Xia Lijian L   Xiao Yi Y   Xing Baocai B   Xiong Bin B   Xu Jianmin J   Xu Jianming J   Xu Nong N   Xu Ruihua R   Xu Zhongfa Z   Yang Yue Y   Yao Hongwei H   Ye Yingjiang Y   Yu Yonghua Y   Yu Yueming Y   Yue Jinbo J   Zhang Jingdong J   Zhang Jun J   Zhang Suzhan S   Zhang Wei W   Zhang Yanqiao Y   Zhang Zhen Z   Zhang Zhongtao Z   Zhao Lin L   Zhao Ren R   Zhou Fuxiang F   Zhou Jian J   Jin Jing J   Gu Jin J   Shen Lin L  

Journal of hematology & oncology 20190214 1


The lungs are the second most common site of metastasis for colorectal cancer (CRC) after the liver. Rectal cancer is associated with a higher incidence of lung metastases compared to colon cancer. In China, the proportion of rectal cancer cases is around 50%, much higher than that in Western countries (nearly 30%). However, there is no available consensus or guideline focusing on CRC with lung metastases. We conducted an extensive discussion and reached a consensus of management for lung metast  ...[more]

Similar Datasets

| S-EPMC11305662 | biostudies-literature
| S-EPMC3719918 | biostudies-literature
| S-EPMC3719916 | biostudies-literature
| S-EPMC8264326 | biostudies-literature
| S-EPMC9801175 | biostudies-literature
| S-EPMC10388578 | biostudies-literature
| S-EPMC7815365 | biostudies-literature
| S-EPMC9359944 | biostudies-literature